Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Jan-Feb 2018;20(1):93-94.
doi: 10.4103/1008-682X.196855.

Multiparametric Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy With Semi-Robotic Navigation in the Chinese Population: Initial Results

Affiliations
Free PMC article

Multiparametric Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy With Semi-Robotic Navigation in the Chinese Population: Initial Results

Wai Kit Ma et al. Asian J Androl. .
Free PMC article

Figures

Figure 1
Figure 1
(a) The Artemis elastic fusion platform. (b) An example shows a PIRADS 3 lesion at the left peripheral base and a PIRADS 4 lesion at the right peripheral base of the prostate in a fusion biopsy patient. (c) During the biopsy procedure, the ultrasound probe is docked to the robot-like mechanical arm with encoders (angle-sensing devices) within each joint for tracking of probe position. After fusion of MR images with real-time TRUS images, target lesions will show up as areas of interests in the three-dimensional prostate model. MR: magnetic resonance imaging; TRUS: transrectal ultrasound.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol. 1994;152(6 Pt 2):2304–7. - PubMed
    1. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology. 2010;255:89–99. - PMC - PubMed
    1. Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol. 2013;23:43–50. - PMC - PubMed
    1. Sonn GA, Margolis DJ, Marks LS. Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol. 2014;32:903–11. - PMC - PubMed
    1. Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol. 2011;29:334–42. - PMC - PubMed
Feedback